The relevance of marketing activities in the Swiss prescription drugs market: Two empirical qualitative studies

Purpose – The purpose of this paper is to identify the most relevant marketing factors and examine existing theories and to provide guidance for planning future studies. Since drug markets are very complex, this paper will focus on a particular market/country to reduce some of this complexity.Design/methodology/approach – A serial research study is undertaken to examine the essential marketing success factors by means of two qualitative studies applying Focus group and Delphi survey techniques. Swiss healthcare professionals in middle and senior management positions (Focus group n=5, Delphi group n=11) are asked to voice their personal opinion regarding the importance of various factors that might influence the turnover of prescription drugs. The fundamental findings derived from the Focus group interview are used for the Delphi group survey set‐up. To reach a consensus within the Delphi group, a three‐step interactive procedure is applied. For the evaluation of the Focus group results, a content analysis...

[1]  Andrew T. Ching,et al.  Understanding Firm, Physician and Consumer Choice Behavior in the Pharmaceutical Industry , 2005 .

[2]  David H. Reiley,et al.  The Roles of Marketing, Product Quality and Price Competition in the Growth and Composition of the U.S. Anti-Ulcer Drug Industry , 1994 .

[3]  Thomas R. Stewart,et al.  The Delphi technique and judgmental forecasting , 1987 .

[4]  F. Smith.  HEALTH SERVICES RESEARCH METHODS IN PHARMACY: Focus groups and observation studies , 1998 .

[5]  M. Hollon.  Direct-to-consumer marketing of prescription drugs: creating consumer demand. , 1999, JAMA.

[6]  Michael J. Moore,et al.  Pioneering and Market Share: Is Entry Time Endogenous and does it Matter? , 1991 .

[7]  Gardner Murphy,et al.  A SIMPLE AND RELIABLE METHOD OF SCORING THE THURSTONE ATTITUDE SCALES , 1993 .

[8]  Dennis H. Gensch,et al.  Solving the “Marketing Mix” Problem using Geometric Programming , 1974 .

[9]  J. Rizzo,et al.  Advertising and Competition in the Ethical Pharmaceutical Industry: The Case of Antihypertensive Drugs* , 1999, The Journal of Law and Economics.

[10]  R. Moore,et al.  Indirect comparison of interventions using published randomised trials: systematic review of PDE-5 inhibitors for erectile dysfunction , 2005, BMC urology.

[11]  George Wright,et al.  The Delphi technique as a forecasting tool: issues and analysis , 1999 .

[12]  Gerard J. Tellis,et al.  First to Market, First to Fail? Real Causes of Enduring Market Leadership , 2006 .

[13]  Olaf Helmer,et al.  ANALYSIS OF THE FUTURE: THE DELPHI METHOD , 1967 .

[14]  Deon Nel,et al.  Pharmaceutical Promotion Tools — Their Relative Importance , 1988 .

[15]  R. Royall.  On finite population sampling theory under certain linear regression models , 1970 .

[16]  Murray Turoff,et al.  The Delphi Method: Techniques and Applications , 1976 .

[17]  N. Dalkey,et al.  An Experimental Application of the Delphi Method to the Use of Experts , 1963 .

[18]  Wendy Gordon,et al.  Qualitative Market Research: A Practitioner's and Buyer's Guide , 1988 .

[19]  George Wright,et al.  The Delphi Technique: A Re-Evaluation of Research and Theory , 1991 .

[20]  J. Vernon.  Concentration, Promotion, and Market Share Stability in the Pharmaceutical Industry , 1971 .

[21]  K. Hill,et al.  The methodological worth of the Delphi forecasting technique , 1975 .

[22]  R. Pindyck,et al.  Consumption Externalities and Diffusion in Pharmaceutical Markets: Antiulcer Drugs , 2000 .

[23]  Füsun F. Gönül,et al.  Promotion of Prescription Drugs and Its Impact on Physicians' Choice Behavior , 2001 .

[24]  B. Glitz.  The focus group technique in library research: an introduction. , 1997, Bulletin of the Medical Library Association.

[25]  W. D. Perreault,et al.  Basic marketing: A managerial approach , 1978 .

[26]  J. Bortz,et al.  Forschungsmethoden und Evaluation , 1995 .

[27]  R. Cooper,et al.  Major new products: What distinguishes the winners in the chemical industry? , 1993 .

[28]  Richard A. Krueger,et al.  Focus groups : a practical guide for applied research / by Richard A. Krueger , 1989 .

[29]  D. Dogramatzis.  Pharmaceutical Marketing: A Practical Guide , 2001 .

[30]  T. Rotarius,et al.  Marketing in today's health care environment. , 2001, Health Care Supervisor.

[31]  D. B. Montgomery,et al.  First‐mover advantages , 1988 .

[32]  C. Fornell,et al.  Sources of Market Pioneer Advantages in Consumer Goods Industries , 1985 .

[33]  Iain Black.  Marketing Masterclass — Pharmaceutical marketing strategy: Lessons from the medical literature , 2005 .

[34]  George Wright,et al.  Delphi: A reevaluation of research and theory , 1991 .

[35]  S. Wilkinson.  Focus Groups in Health Research , 1998, Journal of health psychology.

[36]  Pierre Azoulay,et al.  Do Pharmaceutical Sales Respond to Scientific Evidence , 2002 .

[37]  Gerard F Anderson,et al.  Cross-national comparisons of health systems using OECD data, 1999. , 2002, Health affairs.

[38]  Ernst R Berndt,et al.  An analysis of the diffusion of new antidepressants: variety, quality, and marketing efforts. , 2002, The journal of mental health policy and economics.

[39]  Hubert Gatignon,et al.  Order of Entry as a Moderator of the Effect of the Marketing Mix on Market Share , 1996 .

[40]  F. Smith.  Focus groups and observation studies , 1998 .

[41]  Neil H. Borden,et al.  The Concept of the Marketing Mix , 1964 .

[42]  Maija Renko,et al.  Critical innovation characteristics influencing the acceptability of a new pharmaceutical product format , 2007 .

[43]  G. Lilien,et al.  The timing of competitive market entry: an exploratory study of new industrial products , 1990 .

[44]  Fred Collopy,et al.  The role and validity of judgment in forecasting , 1996 .

[45]  Mickey C. Smith.  Principles of pharmaceutical marketing , 1969 .

[46]  D. Burton,et al.  Research Training for Social Scientists , 2000 .

[47]  S. Hart,et al.  Marketing Strategy and Planning in the UK Pharmaceutical Industry: Some Preliminary Findings , 1990 .

[48]  G. Tellis,et al.  Pioneer Advantage: Marketing Logic or Marketing Legend? , 1993 .

[49]  A. Sapienza.  Assessing the R&D capability of the Japanese pharmaceutical industry , 1993 .

[50]  R. Rosen,et al.  Efficacy of tadalafil for the treatment of erectile dysfunction at 24 and 36 hours after dosing: a randomized controlled trial. , 2003, Urology.